Literature DB >> 6696355

Delta virus infection and severe hepatitis. An epidemic in the Yucpa Indians of Venezuela.

S C Hadler, M De Monzon, A Ponzetto, E Anzola, D Rivero, A Mondolfi, A Bracho, D P Francis, M A Gerber, S Thung.   

Abstract

Over a 3-year period, 149 Yucpa Indians in Venezuela developed hepatitis; 34 persons died and at least 22 developed chronic hepatitis. Children and young adults were primarily affected, especially males. Serologic testing showed that hepatitis B virus infection was highly endemic in this population, but also that 65% of patients had hepatitis B virus surface antigen (HBsAg) during or after illness. Most patients had evidence of delta-agent superinfection; 86% of HBsAg-positive patients had delta antibody, and delta antigen was found in specimens taken during autopsies on 7 of 9 patients. Serologic data suggested that most infections were due to delta superinfection of hepatitis B carriers, and that more than 60% of these infections progressed to chronic disease. Delta agent infection, and particularly delta superinfection of hepatitis B carriers, appears to be an ominous occurrence that may develop in populations among whom hepatitis B virus infection is endemic, and who have no other risk factor for delta infection.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6696355     DOI: 10.7326/0003-4819-100-3-339

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  41 in total

1.  Acute delta hepatitis during treatment with adenosine arabinoside monophosphate with resolution of the HBsAg carrier state.

Authors:  G Garcia; A Smedile; K F Bergmann; J L Gerin; P B Gregory; T C Merigan; W S Robinson
Journal:  West J Med       Date:  1990-07

2.  Hepatitis B (HBV), hepatitis C (HCV) and hepatitis delta (HDV) viruses in the Colombian population--how is the epidemiological situation?

Authors:  Mónica Viviana Alvarado-Mora; María Fernanda Gutierrez Fernandez; Michele Soares Gomes-Gouvêa; Raymundo Soares de Azevedo Neto; Flair José Carrilho; João Renato Rebello Pinho
Journal:  PLoS One       Date:  2011-04-29       Impact factor: 3.240

3.  Hepatitis G virus infection in Amerindians and other Venezuelan high-risk groups.

Authors:  F H Pujol; Y E Khudyakov; M Devesa; M E Cong; C L Loureiro; L Blitz; F Capriles; S Beker; F Liprandi; H A Fields
Journal:  J Clin Microbiol       Date:  1998-02       Impact factor: 5.948

4.  Hepatitis D Virus: A Call to Screening.

Authors:  Joseph Ahn; Robert G Gish
Journal:  Gastroenterol Hepatol (N Y)       Date:  2014-10

5.  Prevalence of antibody to delta hepatitis virus in population groups in West Germany and Switzerland.

Authors:  G G Frösner; E Franco; J Altorfer; R H Decker; I K Mushahwar
Journal:  Eur J Clin Microbiol       Date:  1985-04       Impact factor: 3.267

6.  Hepatitis delta infections.

Authors:  K G Nicholson
Journal:  Br Med J (Clin Res Ed)       Date:  1985-05-11

7.  Clinicopathological study of fulminant hepatitis: coinfection with hepatitis B virus and delta agent.

Authors:  S Krajden; F Bishai; S N Huang; A Ronald; F Harris; J Kempston; J Anderson; S Keston
Journal:  CMAJ       Date:  1986-12-01       Impact factor: 8.262

8.  Delta hepatitis: identification, epidemiologic features and prevention.

Authors: 
Journal:  CMAJ       Date:  1986-02-15       Impact factor: 8.262

9.  Production of hepatitis delta virus and suppression of helper hepatitis B virus in a human hepatoma cell line.

Authors:  J C Wu; P J Chen; M Y Kuo; S D Lee; D S Chen; L P Ting
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

10.  Hepatitis D virus genotypes in intravenous drug users in taiwan: decreasing prevalence and lack of correlation with hepatitis B virus genotypes.

Authors:  Jia-Horng Kao; Pei-Jer Chen; Ming-Yang Lai; Ding-Shinn Chen
Journal:  J Clin Microbiol       Date:  2002-08       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.